Perceptions of illness severity in adults with drug-resistant temporal lobe epilepsy.


Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
08 2020
Historique:
received: 04 01 2020
revised: 30 03 2020
accepted: 31 03 2020
pubmed: 18 5 2020
medline: 2 2 2021
entrez: 18 5 2020
Statut: ppublish

Résumé

The purpose of this study was to explore how subjective perceptions of illness severity were described by a sample of participants with drug-resistant epilepsy (DRE) who were considering surgery. A qualitative methodology, constructivist grounded theory, guided all aspects of the study. Data were collected via 51 semi-structured interviews with 35 adults in our multiethnic sample. At interview, the 20 women (57%) and 15 men (43%) ranged in age from 18 to 68 years (mean = 35.6 years) and had lived with epilepsy for an average of 15.4 y (range = 2-44 years). A grounded theory with four interrelated categories was developed to reflect the process by which participants arrived at an explanation of illness severity. Illness severity for participants evolved as participants reflected upon the burdensome impact of uncontrolled seizures on self and others. Epilepsy, when compared with other chronic conditions, was described as less serious, and participants imagined that other peoples' seizures were comparatively worse than their own. Illness severity was not uppermost in participants' minds but emerged as a concept that was both relative and linked to social burden. Perceptions of overall disease severity expanded upon determinants of seizure severity to offer a more complete explanation of what patients themselves did about longstanding, uncontrolled epilepsy. Perceptions of illness severity played a vital role in treatment decision-making with the potential to impact the illness trajectory. How to measure components of illness severity represents a new challenge for outcomes research in DRE.

Identifiants

pubmed: 32417384
pii: S1525-5050(20)30270-5
doi: 10.1016/j.yebeh.2020.107091
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107091

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors confirm that there are no known conflicts of interest associated with this manuscript.

Auteurs

Sandra R Dewar (SR)

Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States of America. Electronic address: sdewar@mednet.ucla.edu.

MarySue V Heilemann (MV)

School of Nursing, University of California Los Angeles, Los Angeles, CA, United States of America.

Jerome Engel (J)

Department of Neurology, University of California Los Angeles, Los Angeles, CA, United States of America; Department of Neurobiology, University of California Los Angeles, Los Angeles, CA, United States of America; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, United States of America; The Brain Research Institute, University of California Los Angeles, Los Angeles, CA, United States of America.

Eunice E Lee (EE)

School of Nursing, University of California Los Angeles, Los Angeles, CA, United States of America.

Huibrie C Pieters (HC)

School of Nursing, University of California Los Angeles, Los Angeles, CA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH